Lee KS - Search Results

1

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: lee ks. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.

2

Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer.

Kong SY, Nam BH, Lee KS, Kwon Y, Lee ES, Seong MW, Lee DH, Ro J. Kong SY, et al. Among authors: lee dh, lee ks, lee es. Clin Chem. 2006 Aug;52(8):1510-5. doi: 10.1373/clinchem.2006.067512. Epub 2006 Jun 15. Clin Chem. 2006. PMID: 16777917

3

Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.

Park IH, Ro J, Lee KS, Kim SN, Yun YH, Nam BH. Park IH, et al. Among authors: lee ks. Invest New Drugs. 2010 Oct;28(5):659-69. doi: 10.1007/s10637-009-9285-x. Epub 2009 Jul 4. Invest New Drugs. 2010. PMID: 19575146 Clinical Trial.

4

Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy.

Jung SY, Kim SK, Nam BH, Min SY, Lee SJ, Park C, Kwon Y, Kim EA, Ko KL, Park IH, Lee KS, Shin KH, Lee S, Kim SW, Kang HS, Ro J. Jung SY, et al. Among authors: lee sj, lee ks, lee s. Ann Surg Oncol. 2010 Jan;17(1):247-53. doi: 10.1245/s10434-009-0710-3. Epub 2009 Sep 24. Ann Surg Oncol. 2010. PMID: 19777177 Clinical Trial.

5

Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.

Park IH, Kwon Y, Ro JY, Lee KS, Ro J. Park IH, et al. Among authors: lee ks. Breast Cancer Res Treat. 2010 Aug;123(1):125-8. doi: 10.1007/s10549-009-0627-3. Epub 2009 Nov 15. Breast Cancer Res Treat. 2010. PMID: 19916047

6

Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.

Jeong JH, Jung SY, Park IH, Lee KS, Kang HS, Kim SW, Kwon Y, Kim EA, Ko KL, Nam BH, Lee S, Ro J. Jeong JH, et al. Among authors: lee ks, lee s. Invest New Drugs. 2012 Feb;30(1):408-16. doi: 10.1007/s10637-010-9555-7. Epub 2010 Oct 5. Invest New Drugs. 2012. PMID: 20922557

7

High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.

Rhee J, Han SW, Cha Y, Ham HS, Kim HP, Oh DY, Im SA, Park JW, Ro J, Lee KS, Park IH, Im YH, Bang YJ, Kim TY. Rhee J, et al. Among authors: lee ks. Breast Cancer Res Treat. 2011 Jan;125(1):107-14. doi: 10.1007/s10549-010-1200-9. Epub 2010 Oct 9. Breast Cancer Res Treat. 2011. PMID: 20936340

8

A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer.

Park IH, Lee KS, Kang HS, Kim SW, Lee S, Jung SY, Kwon Y, Shin KH, Ko K, Nam BH, Ro J. Park IH, et al. Among authors: lee ks, lee s. Invest New Drugs. 2012 Oct;30(5):1972-7. doi: 10.1007/s10637-011-9759-5. Epub 2011 Oct 18. Invest New Drugs. 2012. PMID: 22006161 Clinical Trial.

9

Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01.

Im SA, Lee KS, Ro J, Lee ES, Kwon Y, Ahn JH, Ahn JS, Kim JH, Kang HS, Shin KH, Noh DY, Park IA, Kim SB, Im YH, Ha SW. Im SA, et al. Among authors: lee ks, lee es. Breast Cancer Res Treat. 2012 Apr;132(2):589-600. doi: 10.1007/s10549-011-1852-0. Epub 2011 Nov 18. Breast Cancer Res Treat. 2012. PMID: 22094934 Clinical Trial.

10

Metaplastic breast cancer: clinicopathological features and its prognosis.

Lee H, Jung SY, Ro JY, Kwon Y, Sohn JH, Park IH, Lee KS, Lee S, Kim SW, Kang HS, Ko KL, Ro J. Lee H, et al. Among authors: lee ks, lee s. J Clin Pathol. 2012 May;65(5):441-6. doi: 10.1136/jclinpath-2011-200586. Epub 2012 Mar 12. J Clin Pathol. 2012. PMID: 22412048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,077 results

Search Page